Literature DB >> 21148689

Wide host range and strong lytic activity of Staphylococcus aureus lytic phage Stau2.

Sue-Er Hsieh1, Hsueh-Hsia Lo, Shui-Tu Chen, Mong-Chuan Lee, Yi-Hsiung Tseng.   

Abstract

In searching for an alternative antibacterial agent against multidrug-resistant Staphylococcus aureus, we have isolated and characterized a lytic staphylophage, Stau2. It possesses a double-stranded DNA genome estimated to be about 134.5 kb and a morphology resembling that of members of the family Myoviridae. With an estimated latency period of 25 min and a burst size of 100 PFU/infected cell, propagation of Stau2 in liquid culture gave a lysate of ca. 6 × 10(10) PFU/ml. It was stable at pH 5 to 13 in normal saline at room temperature for at least 4 weeks and at -85°C for more than 2 years, while 1 × 10(9) out of 2 × 10(12) PFU/ml retained infectivity after 36 months at 4°C. Stau2 could lyse 80% of the S. aureus isolates (164/205) obtained from hospitals in Taiwan, with complete lysis of most of the isolates tested within 3 h; however, it was an S. aureus-specific phage because no lytic infection could be found in the coagulase-negative staphylococci tested. Its host range among S. aureus isolates was wider than that of polyvalent phage K (47%), which can also lyse many other staphylococcal species. Experiments with mice demonstrated that Stau2 could provide 100% protection from lethal infection when a multiplicity of infection of 10 was administered immediately after a challenge with S. aureus S23. Considering these results, Stau2 could be considered at least as a candidate for topical phage therapy or an additive in the food industry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148689      PMCID: PMC3028737          DOI: 10.1128/AEM.01848-10

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  26 in total

Review 1.  Bacteriophage therapy.

Authors:  A Sulakvelidze; Z Alavidze; J G Morris
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  Increasing prevalence of methicillin-resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Wen-Hwei Chen; Huei-Ju Pan; Mei-Lin Chen; Shan-Chwen Chang; Kwen-Tay Luh; Fang-Yue Lin
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

Review 3.  Frequency of morphological phage descriptions in the year 2000. Brief review.

Authors:  H W Ackermann
Journal:  Arch Virol       Date:  2001       Impact factor: 2.574

Review 4.  Bacteriophage therapy.

Authors:  W C Summers
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

5.  Bacteriophage phiYeO3-12, specific for Yersinia enterocolitica serotype O:3, is related to coliphages T3 and T7.

Authors:  M Pajunen; S Kiljunen; M Skurnik
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

6.  Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11.

Authors:  Shigenobu Matsuzaki; Masaharu Yasuda; Hiroshi Nishikawa; Masayuki Kuroda; Takako Ujihara; Taro Shuin; Yuan Shen; Zhe Jin; Shigeyoshi Fujimoto; M D Nasimuzzaman; Hiroshi Wakiguchi; Shigeyoshi Sugihara; Tetsuro Sugiura; Shigeki Koda; Asako Muraoka; Shosuke Imai
Journal:  J Infect Dis       Date:  2003-02-07       Impact factor: 5.226

7.  Isolation from sewage influent and characterization of novel Staphylococcus aureus bacteriophages with wide host ranges and potent lytic capabilities.

Authors:  Aidan J Synnott; Ying Kuang; Miki Kurimoto; Keiko Yamamichi; Hidetomo Iwano; Yasunori Tanji
Journal:  Appl Environ Microbiol       Date:  2009-05-01       Impact factor: 4.792

8.  Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus.

Authors:  Linda M Weigel; Don B Clewell; Steven R Gill; Nancye C Clark; Linda K McDougal; Susan E Flannagan; James F Kolonay; Jyoti Shetty; George E Killgore; Fred C Tenover
Journal:  Science       Date:  2003-11-28       Impact factor: 47.728

9.  Vancomycin heteroresistance in methicillin-resistant Staphylococcus aureus, Taiwan.

Authors:  Jiun-Ling Wang; Sung-Pin Tseng; Po-Ren Hsueh; Keiichi Hiramatsu
Journal:  Emerg Infect Dis       Date:  2004-09       Impact factor: 6.883

10.  Current status of antimicrobial resistance in Taiwan.

Authors:  Po-Ren Hsueh; Cheng-Yi Liu; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more
  24 in total

1.  Two Phages, phiIPLA-RODI and phiIPLA-C1C, Lyse Mono- and Dual-Species Staphylococcal Biofilms.

Authors:  Diana Gutiérrez; Dieter Vandenheuvel; Beatriz Martínez; Ana Rodríguez; Rob Lavigne; Pilar García
Journal:  Appl Environ Microbiol       Date:  2015-03-06       Impact factor: 4.792

2.  Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation.

Authors:  D R Alves; A Gaudion; J E Bean; P Perez Esteban; T C Arnot; D R Harper; W Kot; L H Hansen; M C Enright; A Tobias A Jenkins
Journal:  Appl Environ Microbiol       Date:  2014-08-22       Impact factor: 4.792

Review 3.  Biological challenges of phage therapy and proposed solutions: a literature review.

Authors:  Katherine M Caflisch; Gina A Suh; Robin Patel
Journal:  Expert Rev Anti Infect Ther       Date:  2019-12-02       Impact factor: 5.091

4.  The Combination of Salmonella Phage ST-3 and Antibiotics to Prevent Salmonella Typhimurium In Vitro.

Authors:  Min Lu; Bingxin Liu; Wenbin Xiong; Xinchun Liu
Journal:  Curr Microbiol       Date:  2022-10-21       Impact factor: 2.343

5.  Characterization and complete genome sequence analysis of Staphylococcus aureus bacteriophage SA12.

Authors:  Yoonjee Chang; Ju-Hoon Lee; Hakdong Shin; Sunggi Heu; Sangryeol Ryu
Journal:  Virus Genes       Date:  2013-06-18       Impact factor: 2.332

6.  Genomic analysis of Staphylococcus phage Stau2 isolated from medical specimen.

Authors:  Sue-Er Hsieh; Yi-Hsiung Tseng; Hsueh-Hsia Lo; Shui-Tu Chen; Cheng-Nan Wu
Journal:  Virus Genes       Date:  2015-12-26       Impact factor: 2.332

7.  Improved adsorption of an Enterococcus faecalis bacteriophage ΦEF24C with a spontaneous point mutation.

Authors:  Jumpei Uchiyama; Iyo Takemura; Miho Satoh; Shin-ichiro Kato; Takako Ujihara; Kazue Akechi; Shigenobu Matsuzaki; Masanori Daibata
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

8.  Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining?

Authors:  Harald Brüssow
Journal:  MBio       Date:  2012-04-03       Impact factor: 7.867

9.  Bacteriophage as effective decolonising agent for elimination of MRSA from anterior nares of BALB/c mice.

Authors:  Sanjay Chhibber; Paridhi Gupta; Sandeep Kaur
Journal:  BMC Microbiol       Date:  2014-08-12       Impact factor: 3.605

Review 10.  The Staphylococci phages family: an overview.

Authors:  Marie Deghorain; Laurence Van Melderen
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.